Yvonne Saenger

6PUBLICATIONS
84CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 20, 2025
Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma.

Jennifer M Wiggins, Qiao Zhang, Yian Zhang

|Dec 14, 2024
Phase I study of intratumoral injection of talimogene laherparepvec for the treatment of advanced pancreatic cancer.

Karie Runcie, Yadriel Bracero, Avishai Samouha

|Mar 29, 2024
First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors.

Mark Yarchoan, John D Powderly, Bruno R Bastos

|Feb 09, 2024
Immunotherapy Efficacy in Advanced Hepatocellular Carcinoma in a Diverse and Underserved Population in the United States.

Fernand Bteich, Kush Desai, Chenxin Zhang

|Jan 09, 2022
Combination immunotherapy including OncoVEXmGMCSF creates a favorable tumor immune micro-environment in transgenic BRAF murine melanoma.

Robyn D Gartrell, Zoë Blake, Emanuelle M Rizk

|Oct 12, 2019
Biomarkers Predictive of Survival and Response to Immune Checkpoint Inhibitors in Melanoma.

Emanuelle M Rizk, Angelina M Seffens, Megan H Trager

Pageof 1

Frequent Collaborators

1 joint publications

Robyn D Gartrell

1 joint publications

Zoë Blake

1 joint publications

Emanuelle M Rizk

1 joint publications

Ines Simoes